Alyeska Investment Group’s Terns Pharmaceuticals TERN Stock Holding History

Alyeska Investment Group’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100,000	Closed	-$5.27M	–	795
2026 Q1	$5.27M	Hold	100,000	–	–	0.01%	468
2025 Q4	$4.04M	Buy	+100,000	New	+$2.31M	0.01%	477
2025 Q1	–	Sell	-150,000	Closed	-$831K	–	656
2024 Q4	$831K	Hold	150,000	–	–	﹤0.01%	504
2024 Q3	$1.25M	Buy	+150,000	New	+$1.23M	0.01%	449

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Alyeska Investment Group's TERN Position: Q2 2026 in Review

Alyeska Investment Group sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 100,000 shares — an estimated $5.27M sold.

Alyeska Investment Group first reported a position in TERN in Q3 2024 and held it in 4 quarters. The position peaked at $5.27M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Alyeska Investment Group reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Alyeska Investment Group sold 100,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $5.27M.
Alyeska Investment Group first reported a position in Terns Pharmaceuticals in Q3 2024 and held it in 4 quarters.
Alyeska Investment Group's Terns Pharmaceuticals position peaked at $5.27M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.